Drawing for CLOAKED THERAPEUTICS

USPTO serial 86400613

CLOAKED THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 4893522Status 800Registered
Filing date
Status date
Registration date
Jan 26, 2016
Examiner
ANDERSON, CASSONDRA CR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with CLOAKED THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany D. Gehrke

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancerACTIVESep 19, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2025NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Aug 21, 2025RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Aug 21, 202589AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Aug 21, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 16, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 11, 2025E89RTEAS SECTION 8 & 9 RECEIVED—
Jan 26, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 12, 2023NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jan 12, 20238.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jan 6, 2023EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jul 6, 2022PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Jul 5, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 27, 2022ES8RTEAS SECTION 8 RECEIVED—
Jan 26, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 26, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 22, 2015SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 21, 2015CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 2, 2015SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 19, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 5, 2015IUAFUSE AMENDMENT FILED—
Nov 5, 2015EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 5, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 10, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 10, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 18, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 28, 2015ALIEASSIGNED TO LIE—
Jan 7, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 7, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jan 7, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 7, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 7, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 5, 2015DOCKASSIGNED TO EXAMINER—
Sep 30, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance